Revolutionizing Distribution Intelligence: NielsenIQ (NIQ) Launches Advanced Global Distribution Intelligence on Market Data Platform gfknewron®

7.4.2025 09:00:00 CEST | Business Wire | Press release

NIQ´s advanced distribution intelligence is now available on gfknewron®Integrated platform featuring distribution, retail and reseller market information alongside consumer insights and forecasting capabilities.

NielsenIQ (NIQ), a leading market intelligence company, today announced the global launch of gfknewron® Supply Chain on its state-of-the-art gfknewron® platform. For the first time, an intuitive, always-on AI-enabled platform will offer global distributor sales data, helping Tech & Durables clients manage their distribution and channel business. This tool helps manufacturers, distributors, suppliers, and the channel navigate the complexities of managing an end-to-end global supply chain and quickly adapt to market changes, delivering comprehensive distribution market insights in just a few clicks.

“Our clients and partners are now enabled to steer their supply value chain and distribution channel business with precision. By integrating global distribution intelligence with our platform's existing Point-of-Sale market intelligence, consumer insights, and forecasting capabilities, we are taking a major step forward in enabling our clients and partners to achieve greater success,” Tatjana Wismeth, Head of Distribution and Supply Chain Intelligence at NIQ commented. Tatjana added, “As a first, NIQ has managed to bring these complex data sets into one single platform, taking distribution and supply chain intelligence to the next level.”

gfknewron® Supply Chain offers Tech & Durables manufacturers and other users in-depth insights for sell-through market information based on distributor sales data from around 300 distributors across over 45 global markets. The data is updated weekly for 200 product groups across IT, Consumer Electronics, Office, Telecom and Small Domestic Appliances. With 24 individual sales channels being reported, users will receive an unparalleled view of distribution markets.

To enable this comprehensive market view, NIQ has collaborated with the Global Technology Distribution Council (GTDC) and its members. “The GTDC is a proud partner of NIQ and our members are excited to contribute to this great achievement as it truly simplifies working with distribution intelligence. The tool empowers users to easily analyze distributor sales information with great flexibility across markets. Our distributors and vendors are already looking forward to onboarding their teams and increasing their efficiency of sell-through market data analytics,” said Peter van den Berg, General Manager GTDC EMEA.

The tool facilitates quick access and seamless switching between different modules, allowing users to promptly understand growth drivers in distribution markets, brand and sales channel dynamics, price developments as well as identify top selling items on single SKU-level. This helps manufacturers and distributors steer their channel and sales management as well as to optimize their pricing in distribution markets. Thanks to NIQ´s geographical coverage, manufacturers and distributors benefit from global unified distribution intelligence across markets. The tool strengthens collaboration as analytics can easily be combined and shared across teams.

Together with Point-of-Sales information and Consumer Insights, profound market decisions can be made. NIQ´s Forecasting module on Point-of-Sale information complements the users’ view, providing insights on future market expectations.

This first of its kind tool is launching today, on April 7. To receive a live demonstration of the tool, further information, and contact details, click here: https://nielseniq.com/global/en/products/gfknewron-supply-chain-for-manufacturers.

About gfknewron®

gfknewron is an always-on platform that combines market, consumer and brand data supercharged with AI-powered recommendations. It enables companies to gain actionable and connected insights and act at speed to ignite sustainable growth. The platform offers three specific modules: “gfknewron Market” for market and competitor insights, “gfknewron Consumer” for an in-depth consumer understanding and “gfknewron Predict” that delivers recommendations for companies based on market data and AI-powered intelligence.

About NIQ

NielsenIQ (NIQ) is a leading consumer intelligence company, delivering the most complete understanding of consumer buying behavior and revealing new pathways to growth. NIQ combined with GfK in 2023, bringing together two industry leaders with unparalleled global reach. Our global reach spans over 90 countries covering approximately 85% of the world’s population and more than $ 7.2 trillion in global consumer spend. With a holistic retail read and the most comprehensive consumer insights—delivered with advanced analytics through state-of-the-art platforms—NIQ delivers the Full View™.

For more information, please visit www.niq.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250407569574/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press release

The Phase 3 frontMIND study evaluated tafasitamab (Monjuvi®/Minjuvi®) and lenalidomide in addition to R-CHOP, the current standard of care, compared with R-CHOP alone in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL)Positive trends toward progression-free survival (PFS) benefit with tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypesThe frontMIND data support the submission of global regulatory applications for tafasitamab and lenalidomide added to R-CHOP for previously untreated DLBCLThe data are being presented in an oral session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in The Lancet* Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating t

Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press release

The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a

SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release

Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release

News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom